1Zur HH. Papillomavirus in human cancer. Cancer , 1987, 59(10) : 1692-1696.
2Lombard I, Vincent-Salomon A, Validier P, et al. Human papillomavirus genotype as a major determinant of the course of cervical. J Clin Oncol , 1998, 16(8):2613-2619.
3Mclachlin CM. Human papillomavirus in cervical neoplasia: role,risk factors and implications. Clin Lab Med, 2000,20 (2) : 257-270.
4Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection.CMAJ, 2001,164( 7 ) : 1017-1025.
5Munoz N, Bosch FX, de-Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med, 2003, 348 (6) : 518-527.
6Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer, 2004, 111 (2) : 278-285.
7Clavel C, Masure M, Bory JP, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions:a study of 7932 women. Br J Cancer,2001, 84(12) : 1616-1623.
8Lo WK, Wong YF, Chan KM, et al. Prevalence of human papillomavirus in cervical cancer: a muhicenter study in China. Int J Cancer, 2002,100(3) : 327-331.
9Kay P, Meehan K, Williamson AL. The use of nested polymerase chain reaction and restriction fragment length polymorhpism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. J Virol Methods, 2002,105 ( 1 ) : 159-170.
10Speieh N, Sehmitt C, Bollmann R, et al. Human papillomavirus(HPV) study of 2916 cytological samples by PCR and DNA sequencing : genotype spectrum of patients from the west German area. J Med Microbiol, 2004,53 (Pt 2) :125-128.
